Skip to search.
 TSX Up0.07% TSX Ventures Down0.00%

More On CYX.V

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Calyx Bio-Ventures Inc (CYX.V)

-TSXV
0.05 0.00(0.00%) Jul 10, 3:42PM EDT
Add to Portfolio
ProfileGet Profile for:
Calyx Bio-Ventures Inc
450-400 Burrard Street
Vancouver, BC V6C 3A6
Canada - Map
Phone: 604-689-2495
Fax: 604-689-0014
Website: http://www.chromos.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Calyx Bio-Ventures Inc. owns a portfolio of patents related to modifying and engineering agricultural crop traits in Canada. Its technologies include Engineered Trait Loci (ETL) Technology that enhances crops; and REM technology. The company also holds rights to use the artificial chromosome expression (ACE) system for gene therapy and transgenics. In addition, it has interest in and licenses a technology to Agrisoma Biosciences Inc. that uses ETL technology to commercialize a suite of oil quality and crop improvement traits for use in energy feedstock crops. Calyx Bio-Ventures Inc. is headquartered in Vancouver, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Calyx Bio-Ventures Inc

Key Executives 
 PayExercised
Mr. Douglas Johnstone ,
Chief Financial Officer
12.00k0.00
Mr. Donald G. Konantz ,
Chief Exec. Officer and Pres
N/AN/A
Mr. Tom Mamic B.Comm. CA,
Chief Exec. Officer of Agrisoma Biosciences Inc and Pres of Agrisoma Biosciences Inc
N/AN/A
Mr. Alistair Duncan Sr.,
Corp. Sec.
N/AN/A
Dr. Phillip B. Maples Ph.D.,
VP of Clinical Devel. & Manufacturing
N/AN/A
Amounts are as of 2012-12-31 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.